This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
22 Sep 2020

Daewoong to export gastric acid blocker to Mexico

Daewoong Pharmaceutical has signed a deal worth $50 million to supply Mexico’s Moksha8 with gastric acid blocker Fexuprazan. Given the local authorities' approval plan, Moksha8 aims to launch Fexuprazan in the second half of 2022.

Mentioned Companies
Daewoong Pharmaceutical Co.,Ltd
View company profile